Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Nuclear factor-kappa B induction by visfatin in human vascular endothelial cells : its role in MMP-2/9 production and activation

Tools
- Tools
+ Tools

Adya, Raghu, Tan, Bee K., Chen, Jing and Randeva, Harpal S.. (2008) Nuclear factor-kappa B induction by visfatin in human vascular endothelial cells : its role in MMP-2/9 production and activation. Diabetes Care, Vol.31 (No.4). pp. 758-760. ISSN 0149-5992

Full text not available from this repository.
Official URL: http://dx.doi.org/10.2337/dc07-1544

Abstract

OBJECTIVE - Visfatin is elevated in obesity and type 2 diabetes and is thought to be an inflammatory mediator within atherosclerotic lesions and to induce gelatinase activity. We ;investigated the activation of nuclear factor-kappa B (NF-kappa B), a well-known proinflammatory transcription factor, by visfatin in endothelial cells. RESEARCH DESIGN AND METHODS - Human endothelial cells were transfected with pNF-kappa B-Luc plasmid. Using quantitative PCR, Western blot analysis, and gelatin zymography, we studied NF-kappa B signaling in gelatinase-mediated vascular inflammation by visfatin using the NF-kappa B inhibitor BAY 11-7085. RESULTS - Visfatin significantly increased NF-kappa B transcriptional activity (P < 0.001). We also found a significant inhibition of tumor necrosis factor-alpha JN F-alpha) -induced NF-kappa B activityby visfatin (P < 0.001). Furthermore, the NF-kappa B inhibitor significantly negated visfatin-induced matrix metalloprotemase (MMP)-2/9 mRNA expression, protein levels, and gelatinolytic activity (P < 0.001). CONCLUSIONS - Visfatin-induced NF-kappa B signaling in human endothelial cells affects the activation of gelatinases MMP-2 and -9, suggesting an important role of visfatin in the pathogenesis of vascular inflammation in obesity and type 2 diabetes.

Item Type: Journal Article
Subjects: Q Science > QP Physiology
R Medicine > RC Internal medicine
Divisions: Faculty of Medicine > Warwick Medical School > Clinical Sciences Research Institute (CSRI)
Faculty of Medicine > Warwick Medical School > Metabolic and Vascular Health
Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Vascular endothelium, NF-kappa B (DNA-binding protein), Cardiovascular system -- Diseases
Journal or Publication Title: Diabetes Care
Publisher: American Diabetes Association
ISSN: 0149-5992
Date: April 2008
Volume: Vol.31
Number: No.4
Number of Pages: 3
Page Range: pp. 758-760
Identification Number: 10.2337/dc07-1544
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Funder: General Charities of the City of Coventry
URI: http://wrap.warwick.ac.uk/id/eprint/30301

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us